(-)-alpha-phellandrene increases expression ISO RGD:69157 6480464 alpha phellandrene results in increased expression of BTG2 mRNA CTD PMID:25075043 (-)-demecolcine increases expression ISO RGD:69157 6480464 Demecolcine results in increased expression of BTG2 mRNA CTD PMID:23649840 (S)-colchicine decreases expression ISO RGD:69157 6480464 Colchicine results in decreased expression of BTG2 mRNA CTD PMID:24211769 (S)-naringenin multiple interactions ISO RGD:69157 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BTG2 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of BTG2 mRNA CTD PMID:36235125 (S)-naringenin decreases expression ISO RGD:69157 6480464 naringenin metabolite results in decreased expression of BTG2 mRNA CTD PMID:36235125 (S)-nicotine increases expression ISO RGD:69158 6480464 Nicotine results in increased expression of BTG2 mRNA CTD PMID:17456735 1,1-dichloroethene increases expression ISO RGD:69158 6480464 vinylidene chloride results in increased expression of BTG2 mRNA CTD PMID:26682919 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of BTG2 protein CTD PMID:17337753 1,2-dichloroethane increases expression ISO RGD:69158 6480464 ethylene dichloride results in increased expression of BTG2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:69158 6480464 1, 2-Dimethylhydrazine results in decreased expression of BTG2 mRNA CTD PMID:22206623 1,4-dioxane increases expression ISO RGD:69158 6480464 1, 4-dioxane results in increased expression of BTG2 mRNA CTD PMID:33693819 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BTG2 mRNA CTD PMID:17522070 , PMID:30723492 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of BTG2 mRNA CTD PMID:17070881 15-acetyldeoxynivalenol increases expression ISO RGD:69157 6480464 15-acetyldeoxynivalenol results in increased expression of BTG2 mRNA CTD PMID:23792671 17alpha-ethynylestradiol multiple interactions ISO RGD:69158 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BTG2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BTG2 mRNA CTD PMID:12655037 , PMID:17557909 17beta-estradiol decreases expression ISO RGD:69157 6480464 Estradiol results in decreased expression of BTG2 mRNA CTD PMID:24758408 , PMID:31614463 17beta-estradiol multiple interactions ISO RGD:69157 6480464 [Estradiol co-treated with EGF protein] results in decreased expression of BTG2 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of BTG2 mRNA CTD PMID:24758408 , PMID:30165855 1H-pyrazole increases expression ISO RGD:69158 6480464 pyrazole results in increased expression of BTG2 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69158 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69158 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BTG2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BTG2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BTG2 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of BTG2 mRNA] CTD PMID:23196670 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69158 6480464 Tetrachlorodibenzodioxin results in increased expression of BTG2 mRNA CTD PMID:16962184 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69158 6480464 Tetrachlorodibenzodioxin affects the expression of BTG2 mRNA CTD PMID:16611356 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of BTG2 mRNA CTD PMID:17070881 2,4-diaminotoluene increases expression ISO RGD:69158 6480464 2, 4-diaminotoluene results in increased expression of BTG2 mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BTG2 mRNA CTD PMID:21346803 2,6-diaminotoluene decreases expression EXP 6480464 2, 6-diaminotoluene results in decreased expression of BTG2 mRNA CTD PMID:17070881 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one increases expression EXP 6480464 Praziquantel results in increased expression of BTG2 mRNA CTD PMID:21813463 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of BTG2 mRNA CTD PMID:17070881 2-acetamidofluorene increases expression ISO RGD:69158 6480464 2-Acetylaminofluorene results in increased expression of BTG2 mRNA CTD PMID:21607683 2-arachidonoylglycerol increases expression ISO RGD:69158 6480464 glyceryl 2-arachidonate results in increased expression of BTG2 mRNA CTD PMID:28095641 2-nitro-p-phenylenediamine decreases expression EXP 6480464 2-nitro-4-phenylenediamine results in decreased expression of BTG2 mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of BTG2 mRNA CTD PMID:14600272 more ... 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of BTG2 mRNA CTD PMID:17070881 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 , PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:69158 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BTG2 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of BTG2 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69157 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BTG2 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:69157 6480464 Methylcholanthrene results in increased expression of BTG2 mRNA CTD PMID:22100608 4,4'-sulfonyldiphenol decreases expression ISO RGD:69158 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of BTG2 mRNA CTD PMID:33297965 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BTG2 mRNA CTD PMID:14600272 more ... 4-acetylaminofluorene decreases expression EXP 6480464 4-acetylaminofluorene results in decreased expression of BTG2 mRNA CTD PMID:17070881 4-nitro-1,2-phenylenediamine decreases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of BTG2 mRNA CTD PMID:17070881 4-vinylcyclohexene dioxide affects expression ISO RGD:69158 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of BTG2 mRNA CTD PMID:20829426 5-fluorouracil increases expression ISO RGD:69157 6480464 Fluorouracil results in increased expression of BTG2 mRNA CTD PMID:17982676 5-fluorouracil multiple interactions ISO RGD:69157 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of BTG2 mRNA], TP53 protein promotes the reaction [Fluorouracil results in increased expression of BTG2 mRNA] CTD PMID:15016801 , PMID:17982676 6-O-methylguanine multiple interactions ISO RGD:69157 6480464 [O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of BTG2 mRNA CTD PMID:29666243 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of BTG2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:69158 6480464 9 more ... CTD PMID:32553695 7,12-dimethyltetraphene multiple interactions ISO RGD:69158 6480464 [9 more ... CTD PMID:32553695 adefovir pivoxil increases expression ISO RGD:69157 6480464 adefovir dipivoxil results in increased expression of BTG2 mRNA CTD PMID:25596134 adenine decreases expression ISO RGD:69157 6480464 Adenine results in decreased expression of BTG2 mRNA CTD PMID:24211769 aflatoxin B1 affects expression ISO RGD:69157 6480464 Aflatoxin B1 affects the expression of BTG2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:69157 6480464 Aflatoxin B1 results in increased expression of BTG2 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BTG2 mRNA CTD PMID:14600272 more ... aflatoxin B1 multiple interactions ISO RGD:69157 6480464 TP53 protein affects the reaction [Aflatoxin B1 results in increased expression of BTG2 mRNA] CTD PMID:22100608 aflatoxin B1 increases expression ISO RGD:69158 6480464 Aflatoxin B1 results in increased expression of BTG2 mRNA CTD PMID:19770486 all-trans-retinoic acid affects localization ISO RGD:69157 6480464 Tretinoin affects the localization of BTG2 protein CTD PMID:16782888 all-trans-retinoic acid increases expression ISO RGD:69157 6480464 Tretinoin results in increased expression of BTG2 mRNA, Tretinoin results in increased expression of BTG2 protein CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BTG2 mRNA CTD PMID:20488242 all-trans-retinoic acid multiple interactions ISO RGD:69157 6480464 Tretinoin inhibits the reaction [BTG2 protein binds to RARA protein] CTD PMID:16782888 all-trans-retinoic acid affects response to substance ISO RGD:69157 6480464 BTG2 protein affects the susceptibility to Tretinoin CTD PMID:16782888 all-trans-retinol increases expression ISO RGD:69157 6480464 Vitamin A results in increased expression of BTG2 mRNA CTD PMID:17234770 alpha-phellandrene increases expression ISO RGD:69157 6480464 alpha phellandrene results in increased expression of BTG2 mRNA CTD PMID:25075043 alvocidib increases expression ISO RGD:69158 6480464 alvocidib results in increased expression of BTG2 mRNA CTD PMID:21382384 AM-251 multiple interactions ISO RGD:69158 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of BTG2 mRNA] CTD PMID:28095641 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BTG2 mRNA CTD PMID:16483693 antimonite multiple interactions ISO RGD:69157 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA CTD PMID:32076005 antimycin A increases expression ISO RGD:69157 6480464 Antimycin A results in increased expression of BTG2 mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO RGD:69157 6480464 aristolochic acid I results in increased expression of BTG2 mRNA CTD PMID:33212167 arsane affects expression ISO RGD:69157 6480464 Arsenic affects the expression of BTG2 mRNA CTD PMID:33736254 arsane multiple interactions ISO RGD:69157 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of BTG2 mRNA CTD PMID:33736254 arsenic atom affects expression ISO RGD:69157 6480464 Arsenic affects the expression of BTG2 mRNA CTD PMID:33736254 arsenic atom multiple interactions ISO RGD:69157 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of BTG2 mRNA CTD PMID:33736254 arsenite(3-) multiple interactions ISO RGD:69157 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BTG2 mRNA CTD PMID:32076005 arsenous acid increases expression ISO RGD:69157 6480464 Arsenic Trioxide results in increased expression of BTG2 mRNA CTD PMID:20458559 , PMID:22521957 atrazine increases expression ISO RGD:69157 6480464 Atrazine results in increased expression of BTG2 mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:69158 6480464 Benzene results in decreased expression of BTG2 mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene increases expression ISO RGD:69158 6480464 Benzo(a)pyrene metabolite results in increased expression of BTG2 mRNA, Benzo(a)pyrene results in increased expression of BTG2 mRNA CTD PMID:21569818 more ... benzo[a]pyrene increases methylation ISO RGD:69157 6480464 Benzo(a)pyrene results in increased methylation of BTG2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:69157 6480464 Benzo(a)pyrene results in increased expression of BTG2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:69157 6480464 7 more ... CTD PMID:20382639 , PMID:26238291 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of BTG2 mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide increases expression ISO RGD:69158 6480464 Mustard Gas results in increased expression of BTG2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:69158 6480464 Diethylhexyl Phthalate results in decreased expression of BTG2 mRNA CTD PMID:28085963 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BTG2 mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BTG2 mRNA CTD PMID:35192832 bisphenol A increases expression ISO RGD:69158 6480464 bisphenol A results in increased expression of BTG2 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:69157 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BTG2 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of BTG2 mRNA CTD PMID:36235125 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BTG2 mRNA CTD PMID:34947998 bisphenol A increases methylation ISO RGD:69158 6480464 bisphenol A results in increased methylation of BTG2 promoter CTD PMID:27312807 bisphenol A increases expression ISO RGD:69157 6480464 bisphenol A results in increased expression of BTG2 mRNA CTD PMID:27685785 , PMID:29275510 bisphenol F multiple interactions ISO RGD:69157 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BTG2 mRNA CTD PMID:28628672 Brevetoxin B increases expression ISO RGD:69157 6480464 brevetoxin 2 results in increased expression of BTG2 mRNA CTD PMID:20498034 bromoacetate decreases expression ISO RGD:69157 6480464 bromoacetate results in decreased expression of BTG2 mRNA CTD PMID:19753638 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of BTG2 mRNA CTD PMID:24136188 buta-1,3-diene decreases expression ISO RGD:69158 6480464 1, 3-butadiene results in decreased expression of BTG2 mRNA CTD PMID:29038090 cadmium dichloride decreases expression ISO RGD:69158 6480464 Cadmium Chloride results in decreased expression of BTG2 mRNA CTD PMID:24982889 cadmium dichloride affects expression ISO RGD:69157 6480464 Cadmium Chloride affects the expression of BTG2 mRNA CTD PMID:25596134 calcitriol multiple interactions ISO RGD:69157 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BTG2 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:69157 6480464 Calcitriol results in decreased expression of BTG2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:69158 6480464 Nanotubes, Carbon analog results in increased expression of BTG2 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:69158 6480464 Nanotubes, Carbon results in decreased expression of BTG2 mRNA CTD PMID:25620056 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of BTG2 mRNA CTD PMID:19395590 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of BTG2 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:69157 6480464 CGP 52608 promotes the reaction [RORA protein binds to BTG2 gene] CTD PMID:28238834 chloroacetaldehyde increases expression ISO RGD:69157 6480464 chloroacetaldehyde results in increased expression of BTG2 mRNA CTD PMID:25596134 chloroform increases expression EXP 6480464 Chloroform results in increased expression of BTG2 mRNA CTD PMID:17522070 , PMID:21813463 chloroform increases expression ISO RGD:69158 6480464 Chloroform results in increased expression of BTG2 mRNA CTD PMID:9397189 chlorpromazine increases expression ISO RGD:69157 6480464 Chlorpromazine analog results in increased expression of BTG2 mRNA CTD PMID:15924885 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of BTG2 mRNA CTD PMID:18668222 choline multiple interactions ISO RGD:69158 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BTG2 gene CTD PMID:20938992 chromium(3+) trichloride increases expression ISO RGD:69158 6480464 chromic chloride results in increased expression of BTG2 mRNA CTD PMID:12128095 chromium(6+) affects expression ISO RGD:69158 6480464 chromium hexavalent ion affects the expression of BTG2 mRNA CTD PMID:28472532 cidofovir anhydrous increases expression ISO RGD:69157 6480464 Cidofovir results in increased expression of BTG2 mRNA CTD PMID:25596134 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BTG2 mRNA CTD PMID:24880025 cisplatin multiple interactions ISO RGD:69158 6480464 TRP53 protein affects the reaction [Cisplatin results in increased expression of BTG2 mRNA] CTD PMID:22003191 cisplatin increases expression ISO RGD:69157 6480464 Cisplatin results in increased expression of BTG2 mRNA, Cisplatin results in increased expression of BTG2 protein CTD PMID:19561079 more ... cisplatin increases expression ISO RGD:69158 6480464 Cisplatin results in increased expression of BTG2 mRNA CTD PMID:21382384 more ... cisplatin affects response to substance ISO RGD:69157 6480464 BTG2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clodronic acid increases expression ISO RGD:69157 6480464 Clodronic Acid results in increased expression of BTG2 mRNA CTD PMID:25596134 clofibrate multiple interactions ISO RGD:69158 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BTG2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BTG2 mRNA] CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of BTG2 mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO RGD:69158 6480464 cobaltous chloride results in increased expression of BTG2 mRNA CTD PMID:16772336 cocaine affects expression EXP 6480464 Cocaine affects the expression of BTG2 mRNA CTD PMID:20187946 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of BTG2 mRNA CTD PMID:15755911 coumestrol decreases expression ISO RGD:69157 6480464 Coumestrol results in decreased expression of BTG2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:69157 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:69157 6480464 Asbestos, Crocidolite results in increased expression of BTG2 mRNA CTD PMID:18687144 cyclophosphamide increases expression ISO RGD:69157 6480464 Cyclophosphamide results in increased expression of BTG2 mRNA CTD PMID:29445054 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BTG2 mRNA CTD PMID:21865292 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of BTG2 mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:69157 6480464 Cyclosporine results in decreased expression of BTG2 mRNA CTD PMID:25596134 cytarabine increases expression ISO RGD:69158 6480464 Cytarabine results in increased expression of BTG2 mRNA CTD PMID:21382384 DDE increases activity ISO RGD:69157 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of BTG2 protein CTD PMID:27589886 DDT increases expression EXP 6480464 DDT results in increased expression of BTG2 mRNA CTD PMID:30207508 delphinidin affects expression ISO RGD:69157 6480464 delphinidin affects the expression of BTG2 mRNA CTD PMID:19182879 dexamethasone increases expression ISO RGD:69157 6480464 Dexamethasone results in increased expression of BTG2 mRNA CTD PMID:12782123 dexamethasone multiple interactions ISO RGD:69157 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BTG2 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:69157 6480464 Arsenic Trioxide results in increased expression of BTG2 mRNA CTD PMID:20458559 , PMID:22521957 dibutyl phthalate increases expression ISO RGD:69158 6480464 Dibutyl Phthalate results in increased expression of BTG2 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BTG2 mRNA CTD PMID:21266533 , PMID:21745491 dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of BTG2 mRNA CTD PMID:21813463 dieldrin increases expression ISO RGD:69157 6480464 Dieldrin results in increased expression of BTG2 mRNA CTD PMID:31068361 diethyl maleate decreases expression ISO RGD:69158 6480464 diethyl maleate results in decreased expression of BTG2 mRNA CTD PMID:25270620 diethyl maleate multiple interactions ISO RGD:69158 6480464 NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA], TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] CTD PMID:22003191 diethyl maleate increases expression ISO RGD:69158 6480464 diethyl maleate results in increased expression of BTG2 mRNA CTD PMID:22003191 , PMID:34626751 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of BTG2 mRNA CTD PMID:15890375 diethylstilbestrol decreases expression ISO RGD:69158 6480464 Diethylstilbestrol results in decreased expression of BTG2 mRNA CTD PMID:21382384 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of BTG2 mRNA CTD PMID:22193206 dioxygen decreases expression ISO RGD:69157 6480464 Oxygen deficiency results in decreased expression of BTG2 mRNA CTD PMID:25596134 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:69157 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA CTD PMID:32076005 disodium selenite increases expression ISO RGD:69157 6480464 Sodium Selenite results in increased expression of BTG2 mRNA CTD PMID:24383545 divanadium pentaoxide decreases expression ISO RGD:69157 6480464 vanadium pentoxide results in decreased expression of BTG2 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:69157 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases response to substance ISO RGD:69157 6480464 BTG2 results in increased susceptibility to Doxorubicin CTD PMID:18840609 doxorubicin increases expression ISO RGD:69158 6480464 Doxorubicin results in increased expression of BTG2 mRNA CTD PMID:16243910 more ... doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of BTG2 mRNA CTD PMID:12187937 doxorubicin increases expression ISO RGD:69157 6480464 Doxorubicin results in increased expression of BTG2, Doxorubicin results in increased expression of BTG2 mRNA CTD PMID:16705698 , PMID:18840609 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of BTG2 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:69158 6480464 epoxiconazole results in increased expression of BTG2 mRNA CTD PMID:35436446 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of BTG2 mRNA CTD PMID:17522070 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of BTG2 mRNA CTD PMID:15353170 ethanol multiple interactions ISO RGD:69158 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of BTG2 mRNA] more ... CTD PMID:28095641 ethanol increases expression ISO RGD:69158 6480464 Ethanol results in increased expression of BTG2 mRNA, Ethanol results in increased expression of BTG2 protein CTD PMID:28095641 ethyl methanesulfonate increases expression ISO RGD:69157 6480464 Ethyl Methanesulfonate results in increased expression of BTG2 mRNA CTD PMID:23649840 etoposide multiple interactions ISO RGD:69158 6480464 TRP53 protein affects the reaction [Etoposide results in increased expression of BTG2 mRNA] CTD PMID:22003191 etoposide multiple interactions ISO RGD:69157 6480464 TP53 promotes the reaction [Etoposide results in increased expression of BTG2 protein] CTD PMID:27358234 etoposide increases expression ISO RGD:69157 6480464 Etoposide results in increased expression of BTG2 mRNA, Etoposide results in increased expression of BTG2 protein CTD PMID:24211769 , PMID:27358234 etoposide increases expression ISO RGD:69158 6480464 Etoposide results in increased expression of BTG2 mRNA CTD PMID:21382384 , PMID:22003191 fenamidone increases expression ISO RGD:69158 6480464 fenamidone results in increased expression of BTG2 mRNA CTD PMID:27029645 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of BTG2 mRNA CTD PMID:25596134 fluoranthene multiple interactions ISO RGD:69158 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTG2 mRNA CTD PMID:28329830 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of BTG2 mRNA CTD PMID:28263823 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of BTG2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:69158 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BTG2 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:69158 6480464 Folic Acid results in decreased expression of BTG2 mRNA CTD PMID:25629700 folpet increases expression ISO RGD:69158 6480464 folpet results in increased expression of BTG2 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:69157 6480464 Formaldehyde results in increased expression of BTG2 mRNA CTD PMID:17938736 , PMID:23649840 genistein decreases expression ISO RGD:69157 6480464 Genistein results in decreased expression of BTG2 mRNA CTD PMID:16705744 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BTG2 mRNA CTD PMID:22061828 , PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of BTG2 mRNA CTD PMID:24136188 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of BTG2 mRNA CTD PMID:24915197 Goe 6976 multiple interactions ISO RGD:69157 6480464 [Tetradecanoylphorbol Acetate co-treated with Go 6976] results in increased expression of BTG2 mRNA CTD PMID:15302583 hexadecanoic acid multiple interactions ISO RGD:69157 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of BTG2 mRNA CTD PMID:33736254 hydrogen peroxide affects expression ISO RGD:69157 6480464 Hydrogen Peroxide affects the expression of BTG2 mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:69158 6480464 Hydrogen Peroxide results in increased expression of BTG2 mRNA CTD PMID:21382384 hydrogen peroxide increases expression ISO RGD:69157 6480464 Hydrogen Peroxide results in increased expression of BTG2, Hydrogen Peroxide results in increased expression of BTG2 mRNA CTD PMID:12414654 , PMID:18687144 hydroquinone increases expression ISO RGD:69157 6480464 hydroquinone results in increased expression of BTG2 mRNA CTD PMID:23416264 hydroxyurea increases expression ISO RGD:69157 6480464 Hydroxyurea results in increased expression of BTG2 mRNA CTD PMID:24211769 ifosfamide increases expression ISO RGD:69157 6480464 Ifosfamide results in increased expression of BTG2 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:69157 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BTG2 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:69158 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BTG2 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO RGD:69158 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BTG2 gene CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of BTG2 mRNA CTD PMID:22641619 leptomycin B increases expression ISO RGD:69157 6480464 leptomycin B results in increased expression of BTG2 mRNA CTD PMID:20803015 Licochalcone B increases expression ISO RGD:69157 6480464 licochalcone B results in increased expression of BTG2 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:69158 6480464 Lipopolysaccharides results in increased expression of BTG2 mRNA CTD PMID:12057914 lipopolysaccharide decreases expression ISO RGD:69158 6480464 Lipopolysaccharides results in decreased expression of BTG2 mRNA CTD PMID:27339419 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BTG2 mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BTG2 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BTG2 mRNA] CTD PMID:16401727 , PMID:16415329 melatonin decreases expression ISO RGD:69158 6480464 Melatonin results in decreased expression of BTG2 mRNA CTD PMID:28095641 melatonin multiple interactions ISO RGD:69158 6480464 Melatonin inhibits the reaction [Ethanol results in increased expression of BTG2 protein], MIR497 mRNA affects the reaction [Melatonin results in decreased expression of BTG2 mRNA] CTD PMID:28095641 melphalan increases expression ISO RGD:69157 6480464 Melphalan results in increased expression of BTG2 mRNA CTD PMID:22363485 menadione increases expression ISO RGD:69157 6480464 Vitamin K 3 results in increased expression of BTG2 mRNA CTD PMID:12414654 menadione increases expression ISO RGD:69158 6480464 Vitamin K 3 results in increased expression of BTG2 mRNA CTD PMID:21382384 mercury dibromide increases expression ISO RGD:69157 6480464 mercuric bromide results in increased expression of BTG2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:69157 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BTG2 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of BTG2 mRNA CTD PMID:16507785 metacetamol increases expression ISO RGD:69158 6480464 3-hydroxyacetanilide results in increased expression of BTG2 mRNA CTD PMID:18544908 metformin affects expression EXP 6480464 Metformin affects the expression of BTG2 mRNA CTD PMID:25596134 metformin decreases expression EXP 6480464 Metformin results in decreased expression of BTG2 mRNA CTD PMID:31324951 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BTG2 mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of BTG2 mRNA CTD PMID:15890375 more ... methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of BTG2 mRNA CTD PMID:30467583 methotrexate affects response to substance ISO RGD:69157 6480464 BTG2 mRNA affects the susceptibility to Methotrexate CTD PMID:22753658 methoxychlor affects expression ISO RGD:69158 6480464 Methoxychlor affects the expression of BTG2 mRNA CTD PMID:20829426 methyl methanesulfonate multiple interactions ISO RGD:69158 6480464 NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA], TRP53 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA] CTD PMID:22003191 methyl methanesulfonate increases expression ISO RGD:69157 6480464 Methyl Methanesulfonate results in increased expression of BTG2 mRNA CTD PMID:22100608 , PMID:23649840 methyl methanesulfonate increases expression ISO RGD:69158 6480464 Methyl Methanesulfonate results in increased expression of BTG2 mRNA CTD PMID:21382384 , PMID:22003191 methylisothiazolinone increases expression ISO RGD:69157 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of BTG2 mRNA CTD PMID:31629900 mitomycin C increases expression ISO RGD:69158 6480464 Mitomycin results in increased expression of BTG2 mRNA CTD PMID:21382384 , PMID:25270620 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BTG2 mRNA CTD PMID:16809437 myristicin decreases expression ISO RGD:69157 6480464 myristicin results in decreased expression of BTG2 mRNA CTD PMID:24792648 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BTG2 gene CTD PMID:33148267 N-ethyl-N-nitrosourea increases expression ISO RGD:69158 6480464 Ethylnitrosourea results in increased expression of BTG2 mRNA CTD PMID:19100860 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BTG2 mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:69157 6480464 Methylnitronitrosoguanidine results in decreased expression of BTG2 protein CTD PMID:24821435 N-methyl-N-nitrosourea increases expression ISO RGD:69158 6480464 Methylnitrosourea results in increased expression of BTG2 mRNA CTD PMID:21382384 N-nitrosodiethylamine decreases response to substance ISO RGD:69158 6480464 BTG2 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:18393292 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of BTG2 mRNA CTD PMID:19638242 , PMID:21813463 N-nitrosodiethylamine increases expression ISO RGD:69158 6480464 Diethylnitrosamine results in increased expression of BTG2 mRNA CTD PMID:19100860 more ... N-nitrosodiethylamine decreases expression ISO RGD:69158 6480464 Diethylnitrosamine results in decreased expression of BTG2 mRNA CTD PMID:18393292 N-nitrosodiethylamine multiple interactions EXP 6480464 Diethylnitrosamine affects the localization of and results in increased expression of BTG2 protein CTD PMID:19254457 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of BTG2 mRNA CTD PMID:14600272 , PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of BTG2 mRNA CTD PMID:19716841 N-Nitrosopyrrolidine increases expression ISO RGD:69157 6480464 N-Nitrosopyrrolidine results in increased expression of BTG2 mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BTG2 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BTG2 mRNA] CTD PMID:16401727 , PMID:16415329 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of BTG2 protein CTD PMID:17337753 nickel atom increases expression ISO RGD:69158 6480464 Nickel results in increased expression of BTG2 mRNA CTD PMID:12540486 nickel dichloride multiple interactions ISO RGD:69157 6480464 TP53 protein affects the reaction [nickel chloride results in increased expression of BTG2 mRNA] CTD PMID:23566959 nickel dichloride increases expression ISO RGD:69157 6480464 nickel chloride results in increased expression of BTG2 mRNA CTD PMID:23566959 , PMID:28552779 nicotine increases expression ISO RGD:69158 6480464 Nicotine results in increased expression of BTG2 mRNA CTD PMID:17456735 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BTG2 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:69157 6480464 Oxaliplatin results in increased expression of BTG2 mRNA CTD PMID:36536508 ozone multiple interactions ISO RGD:69158 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of BTG2 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:69157 6480464 p-Chloromercuribenzoic Acid results in increased expression of BTG2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:69157 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BTG2 mRNA CTD PMID:27188386 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of BTG2 mRNA CTD PMID:15585946 paracetamol decreases expression ISO RGD:69158 6480464 Acetaminophen results in decreased expression of BTG2 mRNA CTD PMID:17585979 paracetamol increases expression ISO RGD:69157 6480464 Acetaminophen results in increased expression of BTG2 mRNA CTD PMID:22230336 paracetamol affects expression ISO RGD:69158 6480464 Acetaminophen affects the expression of BTG2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BTG2 mRNA CTD PMID:15120968 more ... paracetamol increases expression ISO RGD:69158 6480464 Acetaminophen results in increased expression of BTG2 mRNA CTD PMID:11264010 more ... paracetamol multiple interactions ISO RGD:69158 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BTG2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BTG2 mRNA] CTD PMID:17585979 paraquat increases expression ISO RGD:69158 6480464 Paraquat results in increased expression of BTG2 mRNA CTD PMID:12595580 perfluorobutyric acid increases expression ISO RGD:69158 6480464 perfluorobutyric acid results in increased expression of BTG2 mRNA CTD PMID:34474067 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69158 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BTG2 mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BTG2 gene CTD PMID:33148267 phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of BTG2 mRNA CTD PMID:17616710 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of BTG2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:69158 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of BTG2 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:69158 6480464 Phenobarbital affects the expression of BTG2 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of BTG2 mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:69158 6480464 Phenobarbital results in increased expression of BTG2 mRNA CTD PMID:19482888 phenobarbital decreases expression ISO RGD:69158 6480464 Phenobarbital results in decreased expression of BTG2 mRNA CTD PMID:19270015 phenylmercury acetate increases expression ISO RGD:69157 6480464 Phenylmercuric Acetate results in increased expression of BTG2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:69157 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BTG2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69157 6480464 [Tetradecanoylphorbol Acetate co-treated with Go 6976] results in increased expression of BTG2 mRNA CTD PMID:15302583 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of BTG2 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO RGD:69158 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of BTG2 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of BTG2 mRNA CTD PMID:15890375 pirinixic acid increases expression ISO RGD:69158 6480464 pirinixic acid results in increased expression of BTG2 mRNA CTD PMID:18445702 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BTG2 mRNA CTD PMID:19162173 potassium chloride multiple interactions ISO RGD:69157 6480464 [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of BTG2 mRNA CTD PMID:29691375 progesterone increases expression EXP 6480464 Progesterone results in increased expression of BTG2 mRNA CTD PMID:20726854 propanal increases expression ISO RGD:69157 6480464 propionaldehyde results in increased expression of BTG2 mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:69157 6480464 Quercetin results in increased expression of BTG2 mRNA CTD PMID:21632981 quinomethionate affects expression ISO RGD:69157 6480464 quinomethionate affects the expression of BTG2 mRNA CTD PMID:15387888 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BTG2 mRNA, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of BTG2 mRNA] CTD PMID:16401727 , PMID:16415329 resveratrol multiple interactions ISO RGD:69157 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of BTG2 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:69157 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:69158 6480464 Silicon Dioxide results in increased expression of BTG2 mRNA CTD PMID:19073995 , PMID:23221170 silicon dioxide increases expression ISO RGD:69157 6480464 Silicon Dioxide results in increased expression of BTG2 mRNA CTD PMID:22300531 sodium arsenite increases expression ISO RGD:69158 6480464 sodium arsenite results in increased expression of BTG2 mRNA CTD PMID:22003191 , PMID:36209798 sodium arsenite multiple interactions ISO RGD:69157 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BTG2 mRNA CTD PMID:32076005 sodium arsenite multiple interactions ISO RGD:69158 6480464 NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of BTG2 mRNA], TRP53 protein affects the reaction [sodium arsenite results in increased expression of BTG2 mRNA] CTD PMID:22003191 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of BTG2 mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:69158 6480464 Sodium Fluoride results in decreased expression of BTG2 mRNA CTD PMID:27862939 Soman increases expression EXP 6480464 Soman results in increased expression of BTG2 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:69157 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BTG2 mRNA CTD PMID:36139627 succimer multiple interactions ISO RGD:69158 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG2 mRNA CTD PMID:21641980 sulforaphane increases expression ISO RGD:69157 6480464 sulforaphane results in increased expression of BTG2 mRNA CTD PMID:26833863 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of BTG2 mRNA CTD PMID:21865292 tamibarotene increases expression ISO RGD:69157 6480464 tamibarotene results in increased expression of BTG2 mRNA CTD PMID:15498508 tert-butyl hydroperoxide increases expression ISO RGD:69157 6480464 tert-Butylhydroperoxide results in increased expression of BTG2 mRNA CTD PMID:12414654 tert-butyl hydroperoxide increases expression ISO RGD:69158 6480464 tert-Butylhydroperoxide results in increased expression of BTG2 mRNA CTD PMID:21382384 testosterone multiple interactions ISO RGD:69157 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BTG2 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:69157 6480464 Testosterone results in decreased expression of BTG2 mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:69158 6480464 Tetrachloroethylene results in increased expression of BTG2 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BTG2 mRNA CTD PMID:17522070 tetrachloromethane increases expression ISO RGD:69158 6480464 Carbon Tetrachloride results in increased expression of BTG2 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of BTG2 mRNA CTD PMID:17522070 tetraphene increases expression ISO RGD:69157 6480464 benz(a)anthracene results in increased expression of BTG2 mRNA CTD PMID:22236718 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BTG2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:69158 6480464 titanium dioxide results in increased expression of BTG2 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BTG2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BTG2 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:69157 6480464 torcetrapib results in increased expression of BTG2 mRNA CTD PMID:23228038 trametinib multiple interactions ISO RGD:69157 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BTG2 mRNA CTD PMID:36139627 tributylstannane decreases expression ISO RGD:69158 6480464 tributyltin results in decreased expression of BTG2 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BTG2 mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:69157 6480464 trichostatin A affects the expression of BTG2 mRNA CTD PMID:28542535 triptonide increases expression ISO RGD:69158 6480464 triptonide results in increased expression of BTG2 mRNA CTD PMID:33045310 tungsten increases expression ISO RGD:69158 6480464 Tungsten results in increased expression of BTG2 mRNA CTD PMID:30912803 undecane increases expression EXP 6480464 undecane results in increased expression of BTG2 protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:69157 6480464 Valproic Acid results in decreased expression of BTG2 mRNA CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of BTG2 mRNA CTD PMID:25596134 , PMID:31085223 vancomycin increases expression ISO RGD:69158 6480464 Vancomycin results in increased expression of BTG2 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of BTG2 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BTG2 mRNA CTD PMID:30207508 vincristine increases expression ISO RGD:69157 6480464 Vincristine results in increased expression of BTG2 mRNA CTD PMID:23649840 zidovudine increases expression ISO RGD:69157 6480464 Zidovudine results in increased expression of BTG2 mRNA CTD PMID:23675285 zinc atom multiple interactions ISO RGD:69157 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BTG2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:69157 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BTG2 mRNA CTD PMID:18593933 zoledronic acid decreases expression ISO RGD:69157 6480464 zoledronic acid results in decreased expression of BTG2 mRNA CTD PMID:25596134 zoledronic acid increases expression ISO RGD:69157 6480464 zoledronic acid results in increased expression of BTG2 mRNA CTD PMID:20977926